UK markets closed

Cyteir Therapeutics, Inc. (CYTT)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
3.0100-0.0100 (-0.33%)
At close: 03:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
Operating expenses
Research development
24,861
34,624
30,959
16,765
Selling general and administrative
13,392
13,546
11,300
4,178
Total operating expenses
38,253
48,170
42,259
20,943
Operating income or loss
-38,253
-48,170
-42,259
-20,943
Total other income/expenses net
-
2,109
133
120
Income before tax
-33,215
-46,061
-42,126
-20,823
Income from continuing operations
-33,215
-46,061
-42,126
-20,823
Net income
-33,215
-46,061
-42,126
-20,823
Net income available to common shareholders
-33,215
-46,061
-42,126
-20,823
Basic EPS
-0.93
-1.31
-2.16
-0.87
Diluted EPS
-0.93
-1.31
-2.16
-0.87
Basic average shares
35,546
35,273
19,499
23,890
Diluted average shares
35,546
35,273
19,499
23,890